Sinopharm
1099.HK
#2039
Rank
NZ$13.44 B
Marketcap
$4.47
Share price
-1.22%
Change (1 day)
7.72%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.68

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.68. In 2022 the company made an earnings per share (EPS) of $0.68 an increase over its 2021 EPS that were of $0.67.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.681.3%
2021$0.6710.33%
2020$0.6117.26%
2019$0.525.44%
2018$0.49-0.87%
2017$0.4919.44%
2016$0.4115.3%
2015$0.3617.06%
2014$0.3121.9%
2013$0.2511.82%
2012$0.2325.24%
2011$0.1831.02%
2010$0.143.3%
2009$0.1346.85%
2008$0.0904567.57%
2007$0.05398310.24%
2006$0.01316